A single European patent, win or lose
This article was originally published in Scrip
Executive Summary
Europe's fragmented system of intellectual property protection is frustrating, expensive and awkward. Innovative pharmaceutical companies and their competitors in the generics industry are in rare agreement on the need to reconfigure the current patent regime.